The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer.
Auteurs
Bertucci F, Finetti P, Simeone I, Hendrickx W, Wang E, Marincola FM, Viens P, Mamessier E, Ceccarelli M, Birnbaum D, Bedognetti D
Résumé
The immunologic constant of rejection (ICR) is a broad phenomenon of Th-1 immunity-mediated, tissue-specific destruction.
Lire l‘article